BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 23419600)

  • 1. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
    Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Jacobsen SH; Clausen TR; Worm D; Hartmann B; Rehfeld JF; Damgaard M; Madsen JL; Madsbad S; Holst JJ; Hansen DL
    Int J Obes (Lond); 2013 Nov; 37(11):1452-9. PubMed ID: 23419600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial changes in gut regulatory peptides in gastric bypass patients.
    Holdstock C; Zethelius B; Sundbom M; Karlsson FA; Edén Engström B
    Int J Obes (Lond); 2008 Nov; 32(11):1640-6. PubMed ID: 18794895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery.
    Jensen CZ; Bojsen-Møller KN; Svane MS; Holst LM; Hermansen K; Hartmann B; Wewer Albrechtsen NJ; Kuhre RE; Kristiansen VB; Rehfeld JF; Clausen TR; Holst JJ; Madsbad S
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G661-G672. PubMed ID: 32068442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial.
    Schmidt JB; Pedersen SD; Gregersen NT; Vestergaard L; Nielsen MS; Ritz C; Madsbad S; Worm D; Hansen DL; Clausen TR; Rehfeld JF; Astrup A; Holst JJ; Sjödin A
    Int J Obes (Lond); 2016 Feb; 40(2):281-90. PubMed ID: 26303352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass.
    de Hollanda A; Jiménez A; Corcelles R; Lacy AM; Patrascioiu I; Vidal J
    Surg Obes Relat Dis; 2014; 10(5):814-9. PubMed ID: 24969090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
    Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
    Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
    Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The post-prandial pattern of gut hormones is related to magnitude of weight-loss following gastric bypass surgery: a case-control study.
    Gerner T; Johansen OE; Olufsen M; Torjesen PA; Tveit A
    Scand J Clin Lab Invest; 2014 Apr; 74(3):213-8. PubMed ID: 24472033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal Hormones and Weight Loss Maintenance Following Roux-en-Y Gastric Bypass.
    de Hollanda A; Casals G; Delgado S; Jiménez A; Viaplana J; Lacy AM; Vidal J
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4677-84. PubMed ID: 26505823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.
    Korner J; Bessler M; Cirilo LJ; Conwell IM; Daud A; Restuccia NL; Wardlaw SL
    J Clin Endocrinol Metab; 2005 Jan; 90(1):359-65. PubMed ID: 15483088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.
    le Roux CW; Welbourn R; Werling M; Osborne A; Kokkinos A; Laurenius A; Lönroth H; Fändriks L; Ghatei MA; Bloom SR; Olbers T
    Ann Surg; 2007 Nov; 246(5):780-5. PubMed ID: 17968169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.
    Whitson BA; Leslie DB; Kellogg TA; Maddaus MA; Buchwald H; Billington CJ; Ikramuddin S
    J Surg Res; 2007 Jul; 141(1):31-9. PubMed ID: 17574036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations.
    Jørgensen NB; Dirksen C; Bojsen-Møller KN; Kristiansen VB; Wulff BS; Rainteau D; Humbert L; Rehfeld JF; Holst JJ; Madsbad S; Clausen TR
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E396-406. PubMed ID: 25536209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
    Jiménez A; Casamitjana R; Flores L; Delgado S; Lacy A; Vidal J
    Ann Surg; 2013 May; 257(5):894-9. PubMed ID: 23579541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
    Bojsen-Møller KN; Svane MS; Martinussen C; Dirksen C; Jørgensen NB; Jensen JB; Jensen CZ; Torekov SS; Kristiansen VB; Rehfeld JF; Bork-Jensen J; Grarup N; Hansen T; Hartmann B; Holst JJ; Madsbad S
    Int J Obes (Lond); 2023 Nov; 47(11):1143-1151. PubMed ID: 37653071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.
    Suzuki S; Ramos EJ; Goncalves CG; Chen C; Meguid MM
    Surgery; 2005 Aug; 138(2):283-90. PubMed ID: 16153438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.